Top

Published in:

Open Access 01-07-2017 | Review Article

Minimally invasive pancreatic cancer surgery: What is the current evidence?

Authors: Michał Pędziwiatr, Piotr Małczak, Piotr Major, Jan Witowski, Beata Kuśnierz-Cabala, Piotr Ceranowicz, Andrzej Budzyński

Published in: Medical Oncology | Issue 7/2017

Abstract

Surgery remains the only option to cure pancreatic cancer. Although the use of laparoscopy in oncology is rapidly growing worldwide, its efficacy in pancreatic surgery remains controversial. A number of studies have compared outcomes of minimally invasive and open pancreatic resections. However, they are mostly non-randomized trials including relatively small groups of patients. In addition, most of these studies were conducted in high-volume pancreatic centres. It seems that despite longer operative time, laparoscopy may be beneficial in terms of morbidity, blood loss and hospital stay. Thus far, very little is known about the long-term outcomes of laparoscopic surgery for pancreatic cancer. Our aim was to review current evidence for the use of minimally invasive techniques in patients with pancreatic malignancy.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRefPubMed

Butturini G. Influence of resection margins and treatment on survival in patients with pancreatic cancer. Arch Surg. 2008;143:75–83.CrossRefPubMed

Tumas J, Kvederaviciute K, Petrulionis M, Kurlinkus B, Rimkus A, Sakalauskaite G, et al. Metabolomics in pancreatic cancer biomarkers research. Med Oncol. 2016;33:133.CrossRefPubMed

Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 2016;55:1158–60.CrossRefPubMed

Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389:1011–24.CrossRefPubMed

Kausch W. Das Carcinom der papilla duodeni und seine radikale Entfernung. Beitrage zur Klinischen Chirurgie. 1912;78:439–86.

Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg. 1935;102:763–79.CrossRefPubMedPubMedCentral

Adam MA, Choudhury K, Dinan MA, Reed SD, Scheri RP, Blazer DGI, et al. Minimally invasive versus open pancreaticoduodenectomy for cancer: practice patterns and short-term outcomes among 7061 Patients. Ann Surg. 2015;262:372–7.CrossRefPubMed

Witzigmann H, Diener MK, Kienkötter S, Rossion I, Bruckner T, Werner Bärbel, et al. No need for routine drainage after pancreatic head resection: the dual-center, randomized, controlled PANDRA trial (ISRCTN04937707). Ann Surg. 2016;264:528–37.CrossRefPubMed

10.

Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc. 1994;8:408–10.CrossRefPubMed

11.

Gagner M, Pomp A. Laparoscopic pancreatic resection: is it worthwhile? J Gastrointest Surg. 1997;1:20–5 (discussion 25–6).CrossRefPubMed

12.

Wellner UF, Küsters S, Sick O, Busch C, Bausch D, Bronsert P, et al. Hybrid laparoscopic versus open pylorus-preserving pancreatoduodenectomy: retrospective matched case comparison in 80 patients. Langenbecks Arch Surg. 2014;399:849–56.CrossRefPubMed

13.

Mendoza AS III, Han H-S, Yoon Y-S, Cho JY, Choi Y. Laparoscopy-assisted pancreaticoduodenectomy as minimally invasive surgery for periampullary tumors: a comparison of short-term clinical outcomes of laparoscopy-assisted pancreaticoduodenectomy and open pancreaticoduodenectomy. J Hepato-Biliary-Pancreat Sci. 2015;22:819–24.CrossRef

14.

Wang Y, Bergman S, Piedimonte S, Vanounou T. Bridging the gap between open and minimally invasive pancreaticoduodenectomy: the hybrid approach. Can J Surg. 2014;57:263–70.CrossRefPubMedPubMedCentral

15.

Pędziwiatr M, Małczak P, Pisarska M, Major P, Wysocki M, Stefura T, et al. Minimally invasive versus open pancreatoduodenectomy-systematic review and meta-analysis. Langenbecks Arch Surg. 2017;8:408–11.

16.

Palanivelu C, Jani K, Senthilnathan P, Parthasarathi R, Rajapandian S, Madhankumar MV. Laparoscopic pancreaticoduodenectomy: technique and outcomes. ACS. 2007;205:222–30.

17.

Croome KP, Farnell MB, Que FG, Reid-Lombardo K, Truty MJ, Nagorney DM, et al. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? Ann Surg. 2014;260:633–40.CrossRefPubMed

18.

Stauffer JA, Coppola A, Villacreses D, Mody K, Johnson E, Li Z, et al. Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution. Surg Endosc. 2017. doi:10.1007/s00464-016-5222-1.PubMed

19.

Pessaux P, Varma D, Arnaud J. Pancreaticoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg. 2006;10:607–11.CrossRefPubMed

20.

Weitz J, Rahbari N, Koch M, Büchler MW. The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg. 2010;210:e1–4.CrossRefPubMed

21.

Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA. “Artery-first” approaches to pancreatoduodenectomy. Br J Surg. 2012;99:1027–35.CrossRefPubMed

22.

Pittau G, Sànchez-Cabùs S, Laurenzi A, Gelli M, Cunha AS. Laparoscopic pancreaticoduodenectomy: right posterior superior mesenteric artery “first” approach. Ann Surg Oncol. 2015;22(Suppl 3):S345–8.CrossRefPubMed

23.

Nagakawa Y, Hosokawa Y, Sahara Y, Takishita C, Nakajima T, Hijikata Y, et al. A novel, “artery first” approach allowing safe resection in laparoscopic pancreaticoduodenectomy: the uncinate process first approach. Hepatogastroenterology. 2015;62:1037–40.PubMed

24.

Müller SA, Hartel M, Mehrabi A, Welsch T, Martin DJ, Hinz U, et al. Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg. 2009;13:784–92.CrossRefPubMed

25.

Kaneoka Y, Yamaguchi A, Isogai M. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery. 2009;145:417–25.CrossRefPubMed

26.

Martin RCG, Scoggins CR, Egnatashvili V, Staley CA, McMasters KM, Kooby DA. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg. 2009;144:154–9.CrossRefPubMed

27.

D’Angelo F, Antolino L, Farcomeni A, Sirimarco D, Kazemi Nava A, De Siena M, et al. Neoadjuvant treatment in pancreatic cancer: evidence-based medicine? A systematic review and meta-analysis. Med Oncol. 2017;34:85.CrossRefPubMed

28.

Kendrick ML, Sclabas GM. Major venous resection during total laparoscopic pancreaticoduodenectomy. HPB (Oxford). 2011;13:454–8.CrossRef

29.

Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, et al. Pancreaticoduodenectomy with major vascular resection: a comparison of laparoscopic versus open approaches. J Gastrointest Surg. 2015;19:189–94 (discussion 194).CrossRefPubMed

30.

Giulianotti PC, Addeo P, Buchs NC, Ayloo SM, Bianco FM. Robotic extended pancreatectomy with vascular resection for locally advanced pancreatic tumors. Pancreas. 2011;40:1264–70.CrossRefPubMed

31.

Speicher PJ, Nussbaum DP, White RR, Zani S, Mosca PJ, Blazer DG, et al. Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy. Ann Surg Oncol. 2014;21:4014–9.CrossRefPubMed

32.

Liao C-H, Liu Y-Y, Wang S-Y, Liu K-H, Yeh C-N, Yeh T-S. The feasibility of laparoscopic pancreaticoduodenectomy—a stepwise procedure and learning curve. Langenbecks Arch Surg. 2016. doi:10.1007/s00423-016-1541-x.PubMed

33.

Lidsky ME, Sun Z, Nussbaum DP, Adam MA, Speicher PJ, Blazer DG. Going the extra mile: improved survival for pancreatic cancer patients traveling to high-volume centers. Ann Surg. 2016. doi:10.1097/SLA.0000000000001924.PubMed

34.

Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011;364:2128–37.CrossRefPubMedPubMedCentral

35.

Adam MA, Thomas S, Youngwirth L, Pappas T, Roman SA, Sosa JA. Defining a hospital volume threshold for minimally invasive pancreaticoduodenectomy in the United States. JAMA Surg. 2017;152:336–42.CrossRefPubMed

36.

Cuschieri A. Laparoscopic surgery of the pancreas. J R Coll Surg Edinb. 1994;39:178–84.PubMed

37.

Edwin B, Sahakyan MA, Hilal MA, Besselink MG, Braga M, Fabre J-M, et al. Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference. Surg Endosc. 2017;31:2023–41.CrossRefPubMed

38.

de Rooij T, Besselink MG, Shamali A, Butturini G, Busch OR, Edwin B, et al. Pan-European survey on the implementation of minimally invasive pancreatic surgery with emphasis on cancer. HPB. 2016;18:170–6.CrossRefPubMed

39.

Ricci C, Casadei R, Taffurelli G, Pacilio CA, Minni F. Laparoscopic distal pancreatectomy: many meta-analyses, few certainties. Updates Surg. 2016;68:225–34.CrossRefPubMed

40.

Riviere D, Gurusamy KS, Kooby DA, Vollmer CM, Besselink MG, Davidson BR, et al. Laparoscopic versus open distal pancreatectomy for pancreatic cancer. Gurusamy KS, editor. Chichester, UK: Wiley; 2016.

41.

Røsok BI, de Rooij T, van Hilst J, Diener MK, Allen PJ, Vollmer CM, et al. Minimally invasive distal pancreatectomy. HPB (Oxford). 2017;19:205–14.CrossRef

42.

Nigri G, Rosman AS, Petrucciani N, Fancellu A, Pisano M, Zorcolo L, et al. Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy. Surgery. 2013;153:111–9.CrossRefPubMed

43.

Probst P, Hüttner FJ, Klaiber U, Knebel P. Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomy. Cochrane Database Syst Rev. 2015;6:CD008688.

44.

Choi SH, Kang CM, Kim JY, Hwang HK, Lee WJ. Laparoscopic extended (subtotal) distal pancreatectomy with resection of both splenic artery and vein. Surg Endosc. 2013;27:1412–3.CrossRefPubMed

45.

Fernández-Cruz L, Cosa R, Blanco L, Levi S, López-Boado M-A, Navarro S. Curative laparoscopic resection for pancreatic neoplasms: a critical analysis from a single institution. J Gastrointest Surg. 2007;11:1607–22.CrossRefPubMed

46.

Mekeel KL, Moss AA, Reddy KS, Mulligan DC, Harold KL. Laparoscopic distal pancreatectomy: does splenic preservation affect outcomes? Surg Laparosc Endosc Percutan Tech. 2011;21:362–5.CrossRefPubMed

47.

Ricci C, Casadei R, Taffurelli G, Bogoni S, D’Ambra M, Ingaldi C, et al. Laparoscopic distal pancreatectomy in benign or premalignant pancreatic lesions: is it really more cost-effective than open approach? J Gastrointest Surg. 2015;19:1415–24.CrossRefPubMed

48.

Braga M, Pecorelli N, Ferrari D, Balzano G, Zuliani W, Castoldi R. Results of 100 consecutive laparoscopic distal pancreatectomies: postoperative outcome, cost-benefit analysis, and quality of life assessment. Surg Endosc. 2015;29:1871–8.CrossRefPubMed

49.

Coolsen MME, van Dam RM, van der Wilt AA, Slim K, Lassen K, Dejong CHC. Systematic review and meta-analysis of enhanced recovery after pancreatic surgery with particular emphasis on pancreaticoduodenectomies. World J Surg. 2013;37:1909–18.CrossRefPubMed

50.

Kagedan DJ, Ahmed M, Devitt KS, Wei AC. Enhanced recovery after pancreatic surgery: a systematic review of the evidence. HPB (Oxford). 2015;17:11–6.CrossRef

51.

Pędziwiatr M, Pisarska M, Kisielewski M, Matłok M, Major P, Wierdak M, et al. Is ERAS in laparoscopic surgery for colorectal cancer changing risk factors for delayed recovery? Med Oncol. 2016;33:10–25.CrossRef

52.

Pędziwiatr M, Pisarska M, Major P, Grochowska A, Matłok M, Przęczek K, et al. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes. Eur J Surg Oncol. 2016;42:779–87.CrossRefPubMed

Title: Minimally invasive pancreatic cancer surgery: What is the current evidence?
Authors: Michał Pędziwiatr
Piotr Małczak
Piotr Major
Jan Witowski
Beata Kuśnierz-Cabala
Piotr Ceranowicz
Andrzej Budzyński
Publication date: 01-07-2017
Publisher: Springer US
Published in: Medical Oncology / Issue 7/2017
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-017-0984-4

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Minimally invasive pancreatic cancer surgery: What is the current evidence?

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2017

Advances in systemic therapy for metastatic breast cancer: future perspectives

Why do younger breast cancer patients with blood group O have favorable prognosis?

Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy

Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives

Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial–mesenchymal transition in prostate cancer cells

Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page